Activity of eftozanermin alfa plus venetoclax in preclinical models and patients with acute myeloid leukemia.
Sign Up to like & getrecommendations! Published in 2023 at "Blood"
DOI: 10.1182/blood.2022017333
Abstract: Activation of apoptosis in malignant cells is an established strategy for controlling cancer and is potentially curative. To assess the impact of concurrently inducing the extrinsic and intrinsic apoptosis-signaling pathways in acute myeloid leukemia (AML),… read more here.
Keywords: myeloid leukemia; plus venetoclax; eftozanermin alfa; acute myeloid ... See more keywords